International Journal of Rheumatology

Biologicals


Publishing date
01 Apr 2012
Status
Published
Submission deadline
01 Oct 2011

1Divisão de Reumatologia, Clínica de Oncologia (CLION), Salvador, BA, Brazil

2Zabludowicz Center for Autoimmune Diseases, Tel Hashomer, Israel; Sheba Medical Center, Tel-Aviv University, Tel Aviv, Israel

3Rheumatology Unit, Department of Medicine, Faculty of Medical Sciences, State University of Campinas, Campinas, SP, Brazil


Biologicals

Description

New therapeutical biological agents for rheumatic disease have changed the prognosis of these diseases. In fact, for those patients who do not have good response to conventional therapy, biologicals are an alternative scheme to control disease activity. Knowledge and understanding of these novel therapeutical agents have led to the development of animal models, biological registries in diverse countries, and therapeutical strategies culminating in a better care to patients. We are interested in original and review articles that explore diverse aspects of biologicals in rheumatic diseases in humans and also in animal models. Potential topics include, but are not limited to:

  • Biologicals in rheumatoid arthritis
  • Biologicals in spondyloarthritis
  • Biologicals in juvenile idiopathic arthritis
  • Side effects during the use of biologicals in rheumatic conditions
  • Infections and biologicals
  • Vaccination and biologicals
  • Peculiar and uncommon effects, such as in bone, heart, lungs, endocrine system, of the biological therapy in rheumatic disorders

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijr/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 892873
  • - Editorial

Biologicals

Jozélio Freire de Carvalho | Simone Appenzeller | Yehuda Shoenfeld
  • Special Issue
  • - Volume 2012
  • - Article ID 637452
  • - Research Article

TNF-Alpha in the Locomotor System beyond Joints: High Degree of Involvement in Myositis in a Rabbit Model

Sture Forsgren | Lina Renström | ... | James E. Gaida
  • Special Issue
  • - Volume 2012
  • - Article ID 573528
  • - Review Article

Immunosuppressive Exosomes: A New Approach for Treating Arthritis

Chenjie Yang | Paul D. Robbins
  • Special Issue
  • - Volume 2012
  • - Article ID 369565
  • - Review Article

Risk of Orthopedic Surgical Site Infections in Patients with Rheumatoid Arthritis Treated with Antitumor Necrosis Factor Alfa Therapy

Bernardo Matos da Cunha | Licia Maria Henrique da Mota | Leopoldo Luiz dos Santos-Neto
  • Special Issue
  • - Volume 2012
  • - Article ID 578641
  • - Review Article

Biological Therapy in Systemic Lupus Erythematosus

Mariana Postal | Lilian TL Costallat | Simone Appenzeller
  • Special Issue
  • - Volume 2012
  • - Article ID 946048
  • - Review Article

Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future Directions

Atsushi Ogata | Toshio Tanaka
  • Special Issue
  • - Volume 2012
  • - Article ID 203819
  • - Review Article

Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease

Courtney L. Kraus | Susan M. Culican
International Journal of Rheumatology
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision73 days
Acceptance to publication23 days
CiteScore3.700
Journal Citation Indicator0.460
Impact Factor2.3
 Submit Check your manuscript for errors before submitting

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.